Dr Shlaes, author of Antibiotics, The Perfect Storm (Springer) and The Drug Makers (Lulu), has had a thirty year career in anti-infectives spanning academia and industry with a long-standing scientific interest in antimicrobial resistance. Dr Shlaes became Vice President for Infectious Diseases at Wyeth Pharmaceuticals in 1996. There he was an important leader in the development of tigecycline. In 2005, he established a consulting company where he contributed in significant ways to the development of avibactam, eravacycline and lefamulin. Dr Shlaes has since retired. He remains an Editor for Antimicrobial Agents and Chemotherapy, writes a blog – Antibiotics the Perfect Storm – and he continues to be active in antibiotic policy areas.